McMaster Innovation Park

McMaster University and Celesta Capital Launch Partnership to Nurture Development of Canadian Deep Tech Startups

Retrieved on: 
Tuesday, March 5, 2024

SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- McMaster University and Celesta Capital today announced a new collaborative partnership to spur the development of an emerging and sustainable ecosystem of Canadian deep tech entrepreneurs.

Key Points: 
  • SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- McMaster University and Celesta Capital today announced a new collaborative partnership to spur the development of an emerging and sustainable ecosystem of Canadian deep tech entrepreneurs.
  • The partnership was announced at their inaugural joint event – Partnering to Accelerate Deep Tech Commercialization in Canada – held at McMaster Innovation Park.
  • The partnership will advance the commercialization of deep tech – cutting-edge technologies built upon advanced science and engineering innovations – at McMaster and within the broader Canadian research and startup ecosystem.
  • As one of Canada's most research-intensive universities, the long-term partnership will allow McMaster to tap into Celesta's expertise as a leading deep tech venture capital investor and business builder.

Cubic and McMaster Partnership Recognized in 7th Edition of the UITP Awards

Retrieved on: 
Monday, June 5, 2023

Cubic Transportation Systems (CTS), part of Cubic Corporation , and McMaster University today announced that Dr. Hanna Haponenko, postdoc at McMaster Automotive Resource Centre (MARC) , has been recognized with the UITP Young Researcher Award.

Key Points: 
  • Cubic Transportation Systems (CTS), part of Cubic Corporation , and McMaster University today announced that Dr. Hanna Haponenko, postdoc at McMaster Automotive Resource Centre (MARC) , has been recognized with the UITP Young Researcher Award.
  • The honor celebrates her work and contributions towards Mobility Cube — a collaborative program between Cubic and McMaster University in Hamilton, Ontario, Canada, focusing on Artificial Intelligence and Smart Mobility.
  • The award was announced at the UITP Global Public Transport Summit held June 4-7, 2023 in Barcelona.
  • Her dedication to advancing accessibility in transportation has earned her recognition, including the UITP Young Researcher Award.

Unleashing the Power of Virtual Reality: McMaster University & Virtualware’s IMRSV@Mac VR Lab!

Retrieved on: 
Wednesday, May 31, 2023

HAMILTON, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- The Faculty of Engineering at McMaster University, in partnership with the VR company Virtualware (EPA: MLVIR), officially announces the grand opening of the New VR Lab called IMRSV@MAC powered by VIROO®.

Key Points: 
  • HAMILTON, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- The Faculty of Engineering at McMaster University, in partnership with the VR company Virtualware (EPA: MLVIR), officially announces the grand opening of the New VR Lab called IMRSV@MAC powered by VIROO®.
  • IMRSV@MAC is poised to become a leading destination for technology enthusiasts, aiming to accelerate the adoption of VR through collaborative efforts between academia and industry.
  • The VR Lab will serve as a catalyst for the development of future-proof skills in research, career advancement, and professional growth across all sectors.
  • The four-year partnership between McMaster University and Virtualware will leverage each organization’s strengths to accelerate the adoption of VR in academic and enterprise sectors.

Fusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapies for Cancer

Retrieved on: 
Tuesday, May 2, 2023

HAMILTON, ON, May 2, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the opening of its state-of-the-art radiopharmaceutical manufacturing facility. The 27,000 square foot good manufacturing practice (GMP) compliant facility, which is located adjacent to the Company's research and development labs, has clinical and commercial manufacturing scale capabilities designed to support the Company's growing pipeline of targeted alpha therapies (TATs).

Key Points: 
  • HAMILTON, ON, May 2, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the opening of its state-of-the-art radiopharmaceutical manufacturing facility.
  • The 27,000 square foot good manufacturing practice (GMP) compliant facility, which is located adjacent to the Company's research and development labs, has clinical and commercial manufacturing scale capabilities designed to support the Company's growing pipeline of targeted alpha therapies (TATs).
  • "Manufacturing and supply chain are critical components of radiopharmaceutical development and commercialization.
  • The new manufacturing facility, part of a 15-year lease agreement with Hamilton, Ontario-based McMaster University, was built by McMaster and equipped and validated by Fusion.

Virtualware partners with McMaster Engineering to introduce its first VR room in Canada

Retrieved on: 
Tuesday, January 24, 2023

TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Virtualware partners with the Faculty of Engineering at McMaster University to adopt and scale the award-winning VR enterprise platform VIROO®.

Key Points: 
  • TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Virtualware partners with the Faculty of Engineering at McMaster University to adopt and scale the award-winning VR enterprise platform VIROO®.
  • Virtualware and McMaster Engineering are committed to making a global impact not only in education, but also in the enterprise.
  • As a result, the immersive room will be located at McMaster Innovation Park (MIP), Canada’s premier research and innovation park.
  • “Our partnership with McMaster, will accelerate VR adoption across the region, creating valuable opportunities to build the most powerful enterprise VR ecosystem for industry,” says Unai Extremo, CEO & Founder Virtualware.

Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology

Retrieved on: 
Tuesday, November 29, 2022

To overcome these challenges and create effective and truly "off-the-shelf" cell therapies, therapeutic developers are deriving allogeneic (from healthy donors) cell therapies from iPSCs.

Key Points: 
  • To overcome these challenges and create effective and truly "off-the-shelf" cell therapies, therapeutic developers are deriving allogeneic (from healthy donors) cell therapies from iPSCs.
  • These include complex editing and the long manufacturing times required to create edited iPSC-derived master and working cell banks.
  • The SOLUPORE technology facilitates sequential cell modification while maintaining cell health, by efficiently delivering protein and nucleic acid cargo into cells with minimum perturbation.
  • OmniaBio Inc. is a CDMO with pre-clinical to commercial-scale manufacturing capability for cell and gene therapies, and a subsidiary of CCRM.

Technology Company Enedym Inc. Announces New Collaboration with Toyota Tsusho Canada, Inc.

Retrieved on: 
Tuesday, October 4, 2022

Enedym, Inc. (Enedym), the technology company that develops next generation switched reluctance motors (SRMs), electric propulsion, and electrified powertrains, today announced a strategic collaboration with Toyota Tsusho Canada, Inc. (Toyota Tsusho), a Toyota group company and general trading arm of Toyota Motor.

Key Points: 
  • Enedym, Inc. (Enedym), the technology company that develops next generation switched reluctance motors (SRMs), electric propulsion, and electrified powertrains, today announced a strategic collaboration with Toyota Tsusho Canada, Inc. (Toyota Tsusho), a Toyota group company and general trading arm of Toyota Motor.
  • Through the collaboration, Enedym will design and develop SRMs and inverters with rated nominal power of approximately 45kW for use in North America and Japan.
  • The collaborations first output, an electric-powered commercial tugger, will be piloted at one of Toyota Tsushos affiliates located at one of Toyota Motors North American manufacturing plants in 2023.
  • We are pleased to work with the Enedym team to power a new generation of commercial tuggers, said Grant Town, President, Toyota Tsusho Canada.

NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada

Retrieved on: 
Tuesday, September 20, 2022

Biomanufacturing, which involves complex infrastructure and expertise to manufacture and supply new advanced therapies, does not currently exist on a commercial scale in Canada for cell and gene-based technologies or products.

Key Points: 
  • Biomanufacturing, which involves complex infrastructure and expertise to manufacture and supply new advanced therapies, does not currently exist on a commercial scale in Canada for cell and gene-based technologies or products.
  • Project partners ExCellThera, MorphoCell and Aspect Biosystems will deploy resources to advance their respective cell and gene therapy (CGT) programs to proceed to commercial production.
  • Canada is recognized around the world as a leader in the field of life sciences, said Jayson Myers, CEO, NGen.
  • OmniaBios facility will be Canadas first commercial-scale CDMO dedicated to cell and gene therapies and is expected to be the largest facility of its kind in Canada.

Tapping into the Global Market through Asia New Bay Area 5G AIoT Innovative Park

Retrieved on: 
Monday, August 22, 2022

These efforts will make the Asia New Bay Area a pioneer of new generation technology applications and a driver for the 5G digital transformation of industries in Kaohsiung.

Key Points: 
  • These efforts will make the Asia New Bay Area a pioneer of new generation technology applications and a driver for the 5G digital transformation of industries in Kaohsiung.
  • In response, Microsoft and 13 other local and international large-scale companies in the field of 5G AIoT vertical application have settled in the Asia New Bay Area.
  • The Asia New Bay Area 5G AIoT Innovation Park will move towards diversified development, such as pursuing opportunities for industry development, building a talent cultivating center, offering R&D subsidies, and planning for field application.
  • This is to attract entrepreneurs to put R&D roots down in Kaohsiung and utilize the Asia New Bay Area as a test site.

APPOINTMENTS ANNOUNCED TO NORTH AMERICA LIFE SCIENCES CAPITAL MARKETS ADVISORY COUNCIL

Retrieved on: 
Thursday, June 23, 2022

NAVDEEP BAINS, VICE-CHAIR OF GLOBAL INVESTMENT BANKING, AND DR. PAUL GORMAN, MANAGING DIRECTOR, GLOBAL INVESTMENT BANKING, CIBC, JOIN COUNCIL

Key Points: 
  • NAVDEEP BAINS, VICE-CHAIR OF GLOBAL INVESTMENT BANKING, AND DR. PAUL GORMAN, MANAGING DIRECTOR, GLOBAL INVESTMENT BANKING, CIBC, JOIN COUNCIL
    HAMILTON, ON, June 23, 2022 /CNW/ - Ty Shattuck, Chief Executive Officer of McMaster Innovation Park (MIP) today announced new appointments to the Life Sciences Capital Markets Advisory Council at MIP ("Council", or "the Council").
  • "On behalf of the Life Sciences Capital Markets Advisory Council, I am very pleased to announce the appointment of the Honourable Navdeep Bains, Vice-Chair of Global Investment Banking, CIBC, and Dr. Paul Gorman, Managing Director, Global Investment Banking, CIBC, to the Council," Ty Shattuck, CEO of McMaster Innovation Park, commented.
  • The Council supports collaboration within the life sciences ecosystem and specifically in respect to capital deployment and investment for the life sciences, while supporting development of relations between MIP, life sciences companies, entrepreneurs and ventures, capital markets interests and participants.
  • Through their respective networks, members support awareness of the importance of life sciences innovation in Canada, as well as the role of innovation parks such as MIP in the regional life sciences ecosystem.